Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regional cholesterol screening: problems and potentials.

A M Lansing1, R N Barbie, K A Shaheen

  • 1Lipid Center of Humana Heart Institute International, Louisville, KY 40217.

The Journal of the Kentucky Medical Association
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser.

Circulation·2001
Same author

Transmyocardial laser revascularization.

The Annals of thoracic surgery·2000
Same author

Transmyocardial revascularization--late results and mechanisms of action.

The Journal of the Kentucky Medical Association·2000
Same author

Transmyocardial laser revascularization in the patient with unmanageable unstable angina.

The Annals of thoracic surgery·1999
Same author

Factors correlating with risk of mortality after transmyocardial revascularization.

Journal of the American College of Cardiology·1999
Same author

Transmyocardial laser revascularisation.

Lancet (London, England)·1999

Mass cholesterol screening found 16% of individuals at moderate or high risk. Few with abnormal levels sought medical care, and fewer still responded successfully to treatment, indicating challenges in cholesterol management.

Area of Science:

  • Cardiovascular Health
  • Public Health Screening
  • Health Economics

Background:

  • Growing awareness of cholesterol's impact on coronary artery disease (CAD) mortality.
  • New guidelines recommend serum cholesterol below 200 mg/dl for all adults.
  • Previous studies like the Lipid Research Clinics-Coronary Primary Prevention Trial (LRC-CPPT) informed current recommendations.

Purpose of the Study:

  • To evaluate the feasibility and cost-effectiveness of mass cholesterol screening.
  • To assess the follow-up care and treatment response rates for individuals with elevated cholesterol.
  • To understand the practical challenges and potential benefits of public health cholesterol screening initiatives.

Main Methods:

  • Mass cholesterol screening conducted on 3,288 individuals at the Kentucky State Fair.

Related Experiment Videos

  • Data collection on risk levels, physician visits, and treatment outcomes.
  • Cost-effectiveness analysis of identifying and managing elevated cholesterol.

    • Main Results:

    • 16% of participants exhibited moderate or high cholesterol risk levels.
    • A low percentage of individuals with abnormal cholesterol levels visited family physicians.
    • Successful treatment responses were observed in a very small proportion of those treated.
    • The estimated cost for lowering identified elevated cholesterol was approximately $800 per individual.

    Conclusions:

    • Mass cholesterol screening identifies a significant number of at-risk individuals.
    • Suboptimal follow-up and treatment adherence present major challenges in cholesterol management.
    • The cost-effectiveness of mass screening requires careful consideration of patient engagement and treatment success rates.